Sath Shukla insider trades

Open-market stock purchases and sales by Sath Shukla, CEO & President at Spero Therapeutics, Inc, from SEC Form 4 filings since Jul 22, 2019.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • SPRO Spero Therapeutics, Inc: 12 sales, last Feb 5, 2025
  • ZIOP Ziopharm Oncology Inc: other filings, last Jan 29, 2020

Get free alerts when Sath Shukla files a new trade →